U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Head and Neck Carcinoma

MedGen UID:
277580
•Concept ID:
C1335703
•
Neoplastic Process

Definition

The reemergence of carcinoma in the head and neck region after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Head and Neck Carcinoma

Professional guidelines

PubMed

Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience.
Rwigema JC, Heron DE, Ferris RL, Gibson M, Quinn A, Yang Y, Ozhasoglu C, Burton S
Am J Clin Oncol 2010 Jun;33(3):286-93. doi: 10.1097/COC.0b013e3181aacba5. PMID: 19875950
Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance.
Agrawal A, Hammond TH, Young GS, Avon AL, Ozer E, Schuller DE
Laryngoscope 2009 Nov;119(11):2135-40. doi: 10.1002/lary.20527. PMID: 19507214
Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
Fischbein NJ, AAssar OS, Caputo GR, Kaplan MJ, Singer MI, Price DC, Dillon WP, Hawkins RA
AJNR Am J Neuroradiol 1998 Aug;19(7):1189-96. PMID: 9726451Free PMC Article

Recent clinical studies

Etiology

Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
Beddok A, Maynadier X, Krhili S, Ala Eddine C, Champion L, Chilles A, Goudjil F, Zefkili S, Amessis M, Choussy O, Le Tourneau C, Buvat I, Créhange G, Carton M, Calugaru V
Strahlenther Onkol 2023 Oct;199(10):901-909. Epub 2023 May 31 doi: 10.1007/s00066-023-02080-y. PMID: 37256301
Disease-free time stratification in locally recurrent head and neck carcinoma after definitive radiotherapy or chemoradiotherapy.
Gorphe P, Moya-Plana A, Guerlain J, Tao Y, Nguyen F, Breuskin I, Blanchard P, Temam S
Eur Arch Otorhinolaryngol 2022 Jun;279(6):3063-3069. Epub 2021 Oct 14 doi: 10.1007/s00405-021-07116-6. PMID: 34648050
Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.
Strnad V, Lotter M, Kreppner S, Fietkau R
Brachytherapy 2014 Mar-Apr;13(2):187-95. Epub 2013 Nov 6 doi: 10.1016/j.brachy.2013.10.008. PMID: 24211123
Treatment of recurrent head and neck carcinoma involving the carotid artery: carotid reconstruction with ePTFE graft.
He XB, Li JJ, Chen YH, Shu C, Tang QL, Yang XM
Eur Arch Otorhinolaryngol 2011 Dec;268(12):1817-22. Epub 2011 Mar 15 doi: 10.1007/s00405-011-1557-3. PMID: 21400255
CT-guided iodine-125 seed permanent implantation for recurrent head and neck cancers.
Jiang YL, Meng N, Wang JJ, Jiang P, Yuan HSh, Liu C, Qu A, Yang RJ
Radiat Oncol 2010 Jul 30;5:68. doi: 10.1186/1748-717X-5-68. PMID: 20673340Free PMC Article

Diagnosis

Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
Beddok A, Maynadier X, Krhili S, Ala Eddine C, Champion L, Chilles A, Goudjil F, Zefkili S, Amessis M, Choussy O, Le Tourneau C, Buvat I, Créhange G, Carton M, Calugaru V
Strahlenther Onkol 2023 Oct;199(10):901-909. Epub 2023 May 31 doi: 10.1007/s00066-023-02080-y. PMID: 37256301
Reirradiation for recurrent head and neck carcinoma.
Peponi E, Balta S, Tasiou I, Gogou P, Capizzello A, Pitouli E, Tsekeris P
J BUON 2012 Jul-Sep;17(3):465-70. PMID: 23033283
Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance.
Agrawal A, Hammond TH, Young GS, Avon AL, Ozer E, Schuller DE
Laryngoscope 2009 Nov;119(11):2135-40. doi: 10.1002/lary.20527. PMID: 19507214
Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.
Vermeersch H, Loose D, Ham H, Otte A, Van de Wiele C
Eur J Nucl Med Mol Imaging 2003 Dec;30(12):1689-700. Epub 2003 Oct 22 doi: 10.1007/s00259-003-1345-4. PMID: 14574516
Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
Fischbein NJ, AAssar OS, Caputo GR, Kaplan MJ, Singer MI, Price DC, Dillon WP, Hawkins RA
AJNR Am J Neuroradiol 1998 Aug;19(7):1189-96. PMID: 9726451Free PMC Article

Therapy

Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
Beddok A, Maynadier X, Krhili S, Ala Eddine C, Champion L, Chilles A, Goudjil F, Zefkili S, Amessis M, Choussy O, Le Tourneau C, Buvat I, Créhange G, Carton M, Calugaru V
Strahlenther Onkol 2023 Oct;199(10):901-909. Epub 2023 May 31 doi: 10.1007/s00066-023-02080-y. PMID: 37256301
Deep hyperthermia with the HYPERcollar system combined with irradiation for advanced head and neck carcinoma - a feasibility study.
Verduijn GM, de Wee EM, Rijnen Z, Togni P, Hardillo JAU, Ten Hove I, Franckena M, van Rhoon GC, Paulides MM
Int J Hyperthermia 2018 Nov;34(7):994-1001. Epub 2018 May 11 doi: 10.1080/02656736.2018.1454610. PMID: 29747544
CT-guided iodine-125 seed permanent implantation for recurrent head and neck cancers.
Jiang YL, Meng N, Wang JJ, Jiang P, Yuan HSh, Liu C, Qu A, Yang RJ
Radiat Oncol 2010 Jul 30;5:68. doi: 10.1186/1748-717X-5-68. PMID: 20673340Free PMC Article
Frameless stereotactic radiosurgery for recurrent head and neck carcinoma.
Voynov G, Heron DE, Burton S, Grandis J, Quinn A, Ferris R, Ozhasoglu C, Vogel W, Johnson J
Technol Cancer Res Treat 2006 Oct;5(5):529-35. doi: 10.1177/153303460600500510. PMID: 16981796
Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.
Vermeersch H, Loose D, Ham H, Otte A, Van de Wiele C
Eur J Nucl Med Mol Imaging 2003 Dec;30(12):1689-700. Epub 2003 Oct 22 doi: 10.1007/s00259-003-1345-4. PMID: 14574516

Prognosis

Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
Beddok A, Maynadier X, Krhili S, Ala Eddine C, Champion L, Chilles A, Goudjil F, Zefkili S, Amessis M, Choussy O, Le Tourneau C, Buvat I, Créhange G, Carton M, Calugaru V
Strahlenther Onkol 2023 Oct;199(10):901-909. Epub 2023 May 31 doi: 10.1007/s00066-023-02080-y. PMID: 37256301
Disease-free time stratification in locally recurrent head and neck carcinoma after definitive radiotherapy or chemoradiotherapy.
Gorphe P, Moya-Plana A, Guerlain J, Tao Y, Nguyen F, Breuskin I, Blanchard P, Temam S
Eur Arch Otorhinolaryngol 2022 Jun;279(6):3063-3069. Epub 2021 Oct 14 doi: 10.1007/s00405-021-07116-6. PMID: 34648050
Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.
Strnad V, Lotter M, Kreppner S, Fietkau R
Brachytherapy 2014 Mar-Apr;13(2):187-95. Epub 2013 Nov 6 doi: 10.1016/j.brachy.2013.10.008. PMID: 24211123
Reirradiation for recurrent head and neck carcinoma.
Peponi E, Balta S, Tasiou I, Gogou P, Capizzello A, Pitouli E, Tsekeris P
J BUON 2012 Jul-Sep;17(3):465-70. PMID: 23033283
Treatment of recurrent head and neck carcinoma involving the carotid artery: carotid reconstruction with ePTFE graft.
He XB, Li JJ, Chen YH, Shu C, Tang QL, Yang XM
Eur Arch Otorhinolaryngol 2011 Dec;268(12):1817-22. Epub 2011 Mar 15 doi: 10.1007/s00405-011-1557-3. PMID: 21400255

Clinical prediction guides

Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
Beddok A, Maynadier X, Krhili S, Ala Eddine C, Champion L, Chilles A, Goudjil F, Zefkili S, Amessis M, Choussy O, Le Tourneau C, Buvat I, Créhange G, Carton M, Calugaru V
Strahlenther Onkol 2023 Oct;199(10):901-909. Epub 2023 May 31 doi: 10.1007/s00066-023-02080-y. PMID: 37256301
Deep hyperthermia with the HYPERcollar system combined with irradiation for advanced head and neck carcinoma - a feasibility study.
Verduijn GM, de Wee EM, Rijnen Z, Togni P, Hardillo JAU, Ten Hove I, Franckena M, van Rhoon GC, Paulides MM
Int J Hyperthermia 2018 Nov;34(7):994-1001. Epub 2018 May 11 doi: 10.1080/02656736.2018.1454610. PMID: 29747544
Reirradiation for recurrent head and neck carcinoma.
Peponi E, Balta S, Tasiou I, Gogou P, Capizzello A, Pitouli E, Tsekeris P
J BUON 2012 Jul-Sep;17(3):465-70. PMID: 23033283
Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.
Argiris A, Li Y, Forastiere A
Cancer 2004 Nov 15;101(10):2222-9. doi: 10.1002/cncr.20640. PMID: 15452834
High dose methotrexate with and without BCG therapy in advanced head and neck malignancy.
Buechler M, Mukherji B, Chasin W, Nathanson L
Cancer 1979 Mar;43(3):1095-100. doi: 10.1002/1097-0142(197903)43:3<1095::aid-cncr2820430347>3.0.co;2-p. PMID: 311679

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...